⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9391841 | 0.76 | — | — | |
| SCHEMBL1177716 | 0.76 | — | — | |
| SCHEMBL28178660 | 0.74 | — | — | |
| SCHEMBL12854186 | 0.73 | PSIP1 (0.32) | — | |
| SCHEMBL9864562 | 0.71 | ALDH1A1 (0.31) | — | |
| SCHEMBL21621365 | 0.71 | SMN1; SMN2 (0.35) | — | |
| SCHEMBL11480923 | 0.69 | LMNA (0.36) | — | |
| SCHEMBL8199097 | 0.68 | POLB (0.44) | — | |
| SCHEMBL8199101 | 0.67 | AKR1B1 (0.30) | — | |
| SCHEMBL7687591 | 0.67 | ALDH1A1 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-5140125-A | — | — | None | — | — | JP | disclosed |
| JP-5140150-A | — | — | None | — | — | JP | disclosed |
| JP-5140124-A | — | — | None | — | — | JP | disclosed |
| JP-5140123-A | — | — | None | — | — | JP | disclosed |
| US-12612384-B2 | Heterocyclic CYP4A inhibitor compounds and compositions thereof | MBD Co., Ltd. (KR) | 2026-04-28 | — | — | US | disclosed |
| EP-4717266-A2 | OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS | Corcept Therapeutics Incorporated (US) | 2026-04-01 | — | — | EP | disclosed |
| US-20250034140-A1 | OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS | Corcept Therpeutics, Inc. (US) | 2025-01-30 | — | — | US | disclosed |
| US-12139486-B2 | Octahydro fused azadecalin glucocorticoid receptor modulators | CORCEPT THERAPEUTICS, INC. (US) | 2024-11-12 | — | — | US | disclosed |
| US-20240287032-A1 | NOVEL HETEROCYCLIC COMPOUND AND USE THEREOF | MBD Co., Ltd. (KR) | 2024-08-29 | — | — | US | disclosed |
| EP-4219494-A1 | OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS | Corcept Therapeutics Incorporated (US) | 2023-08-02 | — | — | EP | disclosed |
| CN-1029402-C | Process for preparing 5-amino-3-chlorosulfonyl-1, 2, 4-triazole | DOWELANCO (US) | 1995-08-02 | — | — | CN | disclosed |
| CN-1100722-A | Process for the preparation of 5-amino-3-chlorosulfonyl-1,2,4-triazole | DOWELANCO (US) | 1995-03-29 | — | — | CN | disclosed |
| EP-0427336-B1 | Process for the preparation of 5-amino-3-chlorosulfonyl-1,2,4-triazole | DOWELANCO (US) | 1995-02-01 | — | — | EP | disclosed |
| JP-H05140125-A | TRIAZOLE DERIVATIVE AND HERBICIDE | HOKKO CHEM IND CO LTD | 1993-06-08 | — | — | JP | disclosed |
| JP-H05140150-A | TRIAZOLE DERIVATIVE AND HERBICIDE | HOKKO CHEM IND CO LTD | 1993-06-08 | — | — | JP | disclosed |
| JP-H05140124-A | TRIAZOLE DERIVATIVE AND HERBICIDE | HOKKO CHEM IND CO LTD | 1993-06-08 | — | — | JP | disclosed |
| JP-H05140123-A | TRIAZOLE DERIVATIVE AND HERBICIDE | HOKKO CHEM IND CO LTD | 1993-06-08 | — | — | JP | disclosed |
| CN-1051557-A | Process for preparing 5-amino-3-chlorosulfonyl-1, 2, 4-triazole | DOWELANCO (US) | 1991-05-22 | — | — | CN | disclosed |
| EP-0427336-A1 | Process for the preparation of 5-amino-3-chlorosulfonyl-1,2,4-triazole | DOWELANCO (US) | 1991-05-15 | — | — | EP | disclosed |
| US-5008396-A | Process for the preparation of 5-amino-3-chlorosulfonyl-1,2,4-triazole | DOWELANCO (US) | 1991-04-16 | — | — | US | disclosed |